Pam Murphy | IR |
Mark Murray | CEO |
Mike Sofia | Chief Scientific Officer |
Gaston Picchio | Chief Development Officer |
Dave Hastings | CFO |
Keay Nakae | Chardan |
Mayank Mamtani | B Riley FBR |
Good day, ladies and gentlemen, and welcome to the Arbutus Biopharma Corporation 2019 First Quarter Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, today's conference is being recorded. I would not like to introduce your host for today's conference Ms. Pam Murphy. Ma'am you may begin.